At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PRFX PRF Technologies Ltd.
Closed Memorial Day 05-22 16:00:00 EDT
1.49
+0.04
+2.76%
盘后1.42
-0.07-4.70%
19:30 EDT
High1.53Low1.34Vol114.42K
Open1.37D1 Closing1.45Amplitude13.10%
Mkt Cap1.29MTradable Cap1.21MTotal Shares868.80K
T/O162.45KT/O Rate14.15%Tradable Shares808.80K
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

PRF Technologies sells 24,384 unregistered shares to Yorkville for fees
Reuters  ·  05-08
PRF Technologies sells 24,384 unregistered shares to Yorkville for fees
PRF Technologies announces FDA clearance of OcuRing-K NDA
TIPRANKS  ·  04-28
PRF Technologies announces FDA clearance of OcuRing-K NDA
PRF wins FDA IND clearance for OcuRing-K Phase II cataract trial
Reuters  ·  04-28
PRF wins FDA IND clearance for OcuRing-K Phase II cataract trial
Prf Technologies Ltd - to Initiate Phase Ii Trial in U.S. With Enrollment Expected in H2 2026
THOMSON REUTERS  ·  04-28
Prf Technologies Ltd - to Initiate Phase Ii Trial in U.S. With Enrollment Expected in H2 2026
Prf Technologies Announces FDA Clearance of Ind Application for Ocuring™-K Phase Ii Clinical Trial
THOMSON REUTERS  ·  04-28
Prf Technologies Announces FDA Clearance of Ind Application for Ocuring™-K Phase Ii Clinical Trial
What's Going On With Pharma Company PRF Technologies On Tuesday?
Benzinga  ·  04-07
What's Going On With Pharma Company PRF Technologies On Tuesday?
Top Premarket Gainers
MT Newswires Live  ·  04-06
Top Premarket Gainers
Israeli drug delivery firm PainReform's 2025 net loss narrows on reduced R&D expenses
Reuters  ·  03-27
Israeli drug delivery firm PainReform's 2025 net loss narrows on reduced R&D expenses
PRF Technologies In FY25 Had ~$4.1M In Cash, Cash Equivalents, Short-Term Deposits And Restricted Cash And Positive Working Capital Of ~$1.9M
Benzinga  ·  03-27
PRF Technologies In FY25 Had ~$4.1M In Cash, Cash Equivalents, Short-Term Deposits And Restricted Cash And Positive Working Capital Of ~$1.9M
Prf Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms
THOMSON REUTERS  ·  03-27
Prf Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms
PainReform Ltd FY Net Income USD -4.8 Million
THOMSON REUTERS  ·  03-27
PainReform Ltd FY Net Income USD -4.8 Million
PRF Technologies FY2025 operating loss narrows 65.1% to $5.1 million; revenue falls to $17,000
Reuters  ·  03-27
PRF Technologies FY2025 operating loss narrows 65.1% to $5.1 million; revenue falls to $17,000
PRF Technologies Ltd. files Form 3 for COO Aviel Sigal
Reuters  ·  03-19
PRF Technologies Ltd. files Form 3 for COO Aviel Sigal
PRF Technologies Director Ellen S. Baron Files Initial Beneficial Ownership Statement
Reuters  ·  03-19
PRF Technologies Director Ellen S. Baron Files Initial Beneficial Ownership Statement
PRF Technologies files initial beneficial ownership statement for Interim CEO Efraim Cohen-Arazi
Reuters  ·  03-19
PRF Technologies files initial beneficial ownership statement for Interim CEO Efraim Cohen-Arazi
PRF Technologies Ltd. files Form 3 for Executive Chairman Ehud Geller
Reuters  ·  03-19
PRF Technologies Ltd. files Form 3 for Executive Chairman Ehud Geller
PRF Technologies Ltd. files initial beneficial ownership statement for CFO Eyal Broder
Reuters  ·  03-19
PRF Technologies Ltd. files initial beneficial ownership statement for CFO Eyal Broder
PRF Technologies Director Augustine Lawlor Files Initial Beneficial Ownership Statement
Reuters  ·  03-19
PRF Technologies Director Augustine Lawlor Files Initial Beneficial Ownership Statement
PRF Technologies Ltd. director Shavit Asaf files initial beneficial ownership statement
Reuters  ·  03-19
PRF Technologies Ltd. director Shavit Asaf files initial beneficial ownership statement
BRIEF-Prf Technologies Ltd. Announces Commercial Collaboration Agreement With Blade Ranger To Accelerate Large-Scale Deepsolar Commercial Engagements
Reuters  ·  03-17
BRIEF-Prf Technologies Ltd. Announces Commercial Collaboration Agreement With Blade Ranger To Accelerate Large-Scale Deepsolar Commercial Engagements

Introduction

Company Name.
PRF Technologies Ltd.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. It is currently conducting Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. The company was incorporated in 2007 and is based in Tel Aviv, Israel.
Issue price:
--